As Raleigh-Durham’s first High-Performance Shell solution, Catalyst BioCampus offers an advanced building shell infrastructure while remaining flexible for biopharmaceutical companies to translate their breakthroughs into therapies with unprecedented speed. Catalyst BioCampus is currently under construction — with the earliest availability in the market — and is on track to start biomanufacturing in 1 year or sooner and accelerate speed to market by 9-15 months.